Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Empagliflozin 25 mg tablets (Dr. Reddy Laboratories) in healthy adults under fasted conditions
TCTR20230901005Phase 1Unknown
- Sponsor
- Bio-innova
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of empagliflozin (2 arms), sponsored by Bio-innova. Status: unknown.
02
Drugs
empagliflozin
Beyond the preview
Go deeper on TCTR20230901005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230901005.